Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
71,858,757
-
Total 13F shares
-
9,476,962
-
Share change
-
+5,850,554
-
Total reported value
-
$60,096,177
-
Price per share
-
$6.47
-
Number of holders
-
16
-
Value change
-
+$37,810,000
-
Number of buys
-
2
-
Number of sells
-
3
Institutional Holders of SINOVAC BIOTECH LTD. - Common Shares (SVA) as of Q1 2020
As of 31 Mar 2020,
SINOVAC BIOTECH LTD. - Common Shares (SVA) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,476,962 shares.
The largest 10 holders included
Vivo Capital, LLC, ORBIMED ADVISORS LLC, Neumann Advisory Hong Kong Ltd, STATE STREET CORP, Yorktown Management & Research Co Inc, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, Skandinaviska Enskilda Banken AB (publ), GEODE CAPITAL MANAGEMENT, LLC, Eqis Capital Management, Inc., and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
16
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.